# Janux Therapeutics (JANX) — Overview

JANX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/janx

## Price

Last close $10.92 on Nov 16, 2026. 52-week range $10.92 – $34.74.

## Company profile

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $23.3M |
| Revenue (quarter) | $9.3M |
| Revenue growth (year over year) | -7.11% |
| Gross profit (trailing twelve months) | $23.3M |
| Gross margin | 100.00% |
| Net income (trailing twelve months) | −$99.8M |
| Net income (quarter) | −$21.6M |
| Net income growth (year over year) | 11.28% |
| Net margin | -428.74% |
| Return on equity | -10.58% |
| EPS (trailing twelve months) | −$1.59 |
| Book value per share | $14.90 |
| P/E (trailing twelve months) | — |
| Price to book | 0.7 |
| Debt to assets | 7.32% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### Is Janux Therapeutics (JANX) profitable?

No. Janux Therapeutics reported a net loss of $99.8M over the trailing twelve months.

### How much revenue does Janux Therapeutics (JANX) make?

Janux Therapeutics generated $23.3M in revenue over the trailing twelve months, down 7.11% year over year.

### How do I buy stock in Janux Therapeutics (JANX)?

JANX trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).
